Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C129822
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/07/508
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
||
|
FDA ORPHAN DRUG |
200505
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
||
|
FDA ORPHAN DRUG |
200605
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
SYLVANT (AUTHORIZED: GIANT LYMPH NODE HYPERPLASIA)
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
||
|
WHO-ATC |
L04AC11
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
||
|
NDF-RT |
N0000191006
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
T4H8FMA7IM
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
m11726
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
C61084
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
Siltuximab
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
541502-14-1
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
7396
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
WW-87
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
DB09036
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
SILTUXIMAB
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
CHEMBL1743070
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
SUB32552
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
T4H8FMA7IM
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
100000124530
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
1535218
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | RxNorm | ||
|
N0000191004
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | Interleukin-6 Antagonists [MoA] | ||
|
4977
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY | |||
|
9051
Created by
admin on Sat Dec 16 00:36:42 UTC 2023 , Edited by admin on Sat Dec 16 00:36:42 UTC 2023
|
PRIMARY |
ACTIVE MOIETY